Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented in "Game Changing" Session at EAU 2023-03-14 05:11
Telix to Showcase Additional ZIRCON Phase III Data in Kidney Cancer Imaging and Theranostic Pipeline Developments at EAU 2023-03-09 04:51
Telix 2022 Full Year Results: Revenue up 20x in first year of commercial sales, underpins transition to cash flow positive 2023-02-27 14:37
Detailed Results from Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented at ASCO GU 2023-02-20 07:10
Telix Collaboration on Next Generation Urologic-Oncology Theranostic Published in Journal of Nuclear Medicine 2023-02-15 04:51
Telix Reports Fourth Quarter 2022 Financial Results 2023-01-18 08:50
Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update 2023-01-09 06:37
ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances 2022-12-22 06:04
Telix Announces Executive Leadership Appointments 2022-12-05 06:39
Illuccix® Available on High Activity Gallium Generator Technology to Meet High Demand 2022-11-22 20:00
First Patient Dosed in Phase II 'IPAX-Linz' Study of TLX101 for Glioblastoma Therapy 2022-11-22 04:59
Telix Acquires Optimal Tracers 2022-11-14 06:36
Telix to Present at Jefferies London Healthcare Conference 2022 2022-11-11 20:00
Telix Announces Positive Topline Results of ZIRCON Phase III Kidney Cancer Imaging Study 2022-11-07 06:48
Telix Recognised as Company of the Year at AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2022 2022-10-27 10:23
Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide 2022-10-27 06:44
Telix Reports Third Quarter 2022 Financial Results 2022-10-20 06:09
TLX250-CDx Indication Expansion: Preliminary Data Presented at EANM 2022-10-18 06:43
Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market 2022-10-17 13:00
Chinese NMPA Approves Pivotal Phase III Study of TLX591-CDx for Prostate Cancer Imaging 2022-10-17 07:25
1 3 4 5 6 7